 | • レポートコード：MRC2303G084 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の市場調査書によると、世界の肥満外科療法装置市場規模が、予測期間中（2022年-2027年）CAGR 10％で増加すると推測されています。本書では、肥満外科療法装置の世界市場について広く調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、装置別（補助装置、埋込装置）分析、エンドユーザー別（肥満手術クリニック、病院、外来手術センター）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などの項目について記載しています。並びに、本書に記載されている企業情報には、Apollo Endosurgery Inc、Johnson& Johnson、TransEnterrix Inc、Allergenc, Inc、ReShape Medical, Inc、Medtronic Plc、Entero Medica, Inc、Aspire Bariatrics Incなどが含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の肥満外科療法装置市場規模：装置別 - 補助装置の市場規模 - 埋込装置の市場規模 ・世界の肥満外科療法装置市場規模：エンドユーザー別 - 肥満手術クリニックにおける市場規模 - 病院における市場規模 - 外来手術センターにおける市場規模 ・世界の肥満外科療法装置市場規模：地域別 - 北米の肥満外科療法装置市場規模 アメリカの肥満外科療法装置市場規模 カナダの肥満外科療法装置市場規模 メキシコの肥満外科療法装置市場規模 … - ヨーロッパの肥満外科療法装置市場規模 ドイツの肥満外科療法装置市場規模 イギリスの肥満外科療法装置市場規模 フランスの肥満外科療法装置市場規模 … - アジア太平洋の肥満外科療法装置市場規模 中国の肥満外科療法装置市場規模 日本の肥満外科療法装置市場規模 インドの肥満外科療法装置市場規模 … - 南米/中東の肥満外科療法装置市場規模 ブラジルの肥満外科療法装置市場規模 アルゼンチンの肥満外科療法装置市場規模 サウジアラビアの肥満外科療法装置市場規模 ・競争状況 ・市場機会・将来動向 |
The Bariatric Surgery Devices Market is projected to register a CAGR of 10% during the forecast period (2022-2027).
COVID-19 is expected to significantly impact the market’s growth due to the postponement of elective surgeries during the pandemic. For instance, According to the data published by World Economic Forum in 2020, 28 million elective surgeries across the globe got canceled during 12 weeks of peak disruption during the COVID-19 pandemic. Such circumstances have decreased the demand for bariatric surgery devices and limited the market’s growth in the pandemic period. However, during the post-pandemic period, the relaxation of restrictions has increased the patient influx, thereby increasing the demand for bariatric surgery devices and contributing to market growth.
The major factors, such as the prevalence of diabetes and cardiovascular diseases, are driving the market’s growth in the forecast period. For instance, the data published by the European Heart network in 2021 reported that in the European Union, more than 60 million people live with Cardiovascular disease and that nearly 13 million new cases of cardiovascular diseases are diagnosed yearly. Similarly, The International Diabetes Federation 2021 published that approximately 537 million adults live with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The increase in chronic diseases such as diabetes and cardiovascular diseases among the global population led to the increasing demand for bariatric surgery devices, which was attributed to the market growth.
The major factors attributing to the growth of the bariatric surgery market are an increase in obesity among people and a rising prevalence rate of Type 2 diabetes and heart diseases. People with more fat in their bodies are highly likely to be affected by diabetes. Hence, patients are taking certain measures to prevent obesity with bariatric surgeries. For instance, according to the World Health Organization (WHO) May 2022 report on the European region, in the WHO European Region, over 60% of adults and 29% of boys and 27% of girls who are children are overweight or obese and also, as per the same report, overweight and obesity rank fourth among the risk factors for non-communicable diseases in the region, after high blood pressure, unhealthy eating, and cigarette use. Further, according to the December 2021 report of the International Diabetes Federation, it is estimated that about 537 million adults in the age group of 20-79 years were living with diabetes in 2021 across the world and this number is projected to increase to 643 million by 2030. Hence, owing to the high burden of obesity and the increasing prevalence of risk factors for obesity are expected to fuel growth in the bariatric surgery devices market over the forecast period.
Additionally, in September 2021, Olympus launched the POWERSEAL advanced bipolar surgical energy devices to Strengthen its Surgical Portfolio. The POWERSEAL devices can be used in numerous forms of surgical intervention, including bariatric surgical procedures.
Therefore, it is clear that the growing prevalence of diabetes and obesity will significantly drive the market for bariatric surgery devices over the upcoming years. However, the high cost of surgery and lack of knowledge and awareness in developing and underdeveloped nations may restrain the market growth.
Bariatric Surgery Devices Market Trends
The Assisting Devices segment Expected to Hold a Major Market Share in the Bariatric Surgery Devices Market
The Assisting devices are expected to hold a dominating share in the studied market during the forecast period. This is mainly due to the increasing prevalence of the obese population across the globe leading to the demand for Bariatric surgery devices, thereby propelling the market’s growth. For instance, The article published by A-ManisaBiotech in 2020 stated that more than 2 billion adults, 18 years and older, were overweight worldwide. Of these, over 650 million were obese in the world. The World Health Organization (WHO) published in 2021 that modifiable behavioral risk factors such as tobacco use account for over 7.2 million deaths yearly, and 1.6 million deaths annually can be attributed to insufficient physical activity.
Additionally, the increasing innovative launches to simplify surgeries are expected to drive the market’s growth. For instance, in February 2022, Stryker launched the PROsrep MICA SOLO guide to simplify minimally invasive Bunion procedures designed by a solo surgeon. Such innovative launches and increasing cardiovascular disorders are expected to boost the growth of the studied segment during the forecast period.
Thus, due to the above-mentioned reasons, the assisting devices segment is expected to propel over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period.
The market for Bariatric Surgery devices in the United States is driven by the increasing use of advanced technology in healthcare systems and the country’s rising burden of chronic diseases. For instance, according to the Center for Disease Control and Prevention (CDC) 2020 statistics, 6 in 10 adults in the United States have a chronic disease, and 4 in 10 adults in the United States have two or more. The major factors attributing to the growth are a deskbound lifestyle lacking physical activity, lack of proper diet, anxiety, and stress resulting in chronic diseases such as diabetes and obesity, leading to rising in the prevalence of multiple cardiovascular diseases like CAD, strokes, and atrial fibrillation in the United States increased the demand for bariatric surgery devices. For instance, in 2022, the Centers for Disease Control and Prevention mentioned that more than 795,000 people in the United States have a stroke every year. About 610,000 of these are first or new strokes.
As per the United States, National Health Statistics Reports published in June 2021, among adults aged 20 and over, the prevalence of obesity was 41.9%, severe obesity was 9.2%, and diabetes was 14.8%. The increase in the prevalence of obesity among the population is expected to drive the bariatric surgery market in the United States. Furthermore, the presence of established healthcare infrastructure along with the presence of a large number of market players in the country is expected to boost market growth over the forecast period. For instance, in September 2020, Ethicon, part of Johnson & Johnson Medical Devices Companies, launched ECHELON ENDOPATH Staple Line Reinforcement (SLR), a buttressing device designed to reduce potential complications during bariatric procedures
Moreover, Furthermore, product launches by the key market players in the region are expected to boost the market growth. For instance, in May 2021, Standard Bariatrics announced the launch of its novel Titan SGS stapling technology, specifically designed for bariatric sleeve surgery. Also, the device has been cleared by the United States Food and Drug Administration (FDA). These new product launches by major players for new closure devices propel the studied market’s growth. Similarly, in June 2021, Ethicon, part of the Johnson & Johnson Medical Devices Companies launched the ENSEAL X1 Curved Jaw Tissue Sealer for colorectal, gynecological, bariatric surgery, and thoracic procedures.
Thus, due to the above-mentioned factors, the market is expected to witness a boost in growth in this region during the forecast period.
Bariatric Surgery Devices Market Competitor Analysis
The Bariatric Surgery Devices Market is fragmented and competitive and consists of several major players. In terms of market share, a few major players dominate the market. Some companies currently dominating the market are Apollo Endo Surgery Inc, Johnson & Johnson, TransEnterrix Inc, Allergenc, Inc, Reshape Medical, Inc, Medtronic plc, Entero Medica Inc, Asprie Bariatrics Inc, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Obese Population
4.2.2 Prevalence of Diabetes and Heart Diseases
4.3 Market Restraints
4.3.1 Lack of Knowledge and awareness in Developing and Underdeveloped Nations
4.3.2 High Cost of surgery
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Device Type
5.1.1 Assisting Devices
5.1.2 Implantable Devices
5.2 By End User
5.2.1 Bariatric Surgery Clinics
5.2.2 Hospitals
5.2.3 Ambulatory Surgical Centers
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Apollo Endosurgery Inc
6.1.2 Johnson& Johnson
6.1.3 TransEnterrix Inc
6.1.4 Allergenc, Inc
6.1.5 ReShape Medical, Inc
6.1.6 Medtronic Plc
6.1.7 Entero Medica, Inc
6.1.8 Aspire Bariatrics Inc
7 MARKET OPPORTUNITIES AND FUTURE TRENDS